Our results provide supporting evidence that maintains that the HSP90-STAT5 axis is critical for sustaining immunosurveillance of tumor-infiltrating CD8+ T cells and that disrupting RIG-I-HSP90 interaction may help maintain the active status of this axis. This evidence concerns the gene STAT5A and neoplasm.